Dharmacon


Horizon Discovery is a leading provider of cell engineering solutions, leveraging expertise in gene editing and gene modulation to support scientific research, drug discovery, and therapeutic applications. The company offers a broad portfolio of tools and services, including research reagents, screening and cell line engineering services, bio-production cell lines, and base editing technologies. Horizon's mission is to transform human health through innovative gene editing applications, supported by a strategic focus on expanding tools, growing revenue, automating processes, and continuous innovation. With a global customer base across academia, biotech, and pharma, Horizon aims to be the 'go-to' provider of cell engineering solutions, advancing precision medicine and biopharmaceutical development.

Industries

biotechnology
genetics
medical

Nr. of Employees

large (251-1000)

Dharmacon

Lafayette, Colorado, United States, North America


Products

Engineered cell line products (knockout/knock-in/isogenic banks)

Ready-to-ship engineered cell models including a large isogenic HAP1 knockout bank (>7,500 models), cancer-related knock-in/knockout lines and stable Cas9/dCas9 expressing lines.

Gene editing and modulation reagents (CRISPR and RNAi)

Catalog of gene editing and gene modulation reagents including synthetic guide RNAs, nucleases, siRNA/shRNA pools and screening libraries.

cDNA and ORF clone collections

Mammalian and non-mammalian cDNA and ORF clone collections for overexpression studies, available as individual clones, plates, lentiviral ORFs and genome-scale libraries.

Reference standards (cell line-derived)

Molecular reference standards derived from cell lines and custom-designed reference materials to support assay workflow control and diagnostics development.

Transfection and ancillary reagents

Reagents and consumables to support nucleic acid delivery and routine laboratory workflows for gene editing and modulation experiments.

Bioproduction cell lines (CHO platforms)

Engineered CHO expression cell lines and platforms optimized for biologics production including lines designed to enhance antibody-dependent cellular cytotoxicity (ADCC) and other production traits.


Services

Functional genomic screening services

Arrayed and pooled screening workflows including CRISPR and RNAi screens, single-cell CRISPR screens and pooled tiled base-editing screens.

Cell line engineering services

Custom generation of knockout and knock-in cell models, stable Cas9/dCas9 cell lines and bioproduction cell engineering for CHO platforms.

Custom oligonucleotide synthesis

Custom synthesis of RNA and DNA oligonucleotides including siRNA, ASOs and single-strand RNA.

Immune cell screening and compound assay services

Assay development and compound screening in immune cell contexts, including T cell activation, regulatory T cell polarization/suppression and mixed lymphocyte reaction assays.

Bioinformatics and experimental design tools

Online calculators and design tools for CRISPR guide design, HDR donor design, primer analysis, Tm calculations and qPCR efficiency estimations.

Reference standard design and custom reference standards

Design and manufacture of cell line–derived molecular reference standards and custom reference materials for assay validation and diagnostics.

View All Services

Expertise Areas

  • Cell line engineering
  • Functional genomic screening
  • Gene editing and base editing
  • RNA interference and gene modulation
  • Show More (6)

Key Technologies

  • CRISPR-based gene editing
  • Base editing
  • CRISPR activation/interference (CRISPRa/CRISPRi)
  • RNAi (siRNA, shRNA, microRNA)
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.